Hongping Xia

5PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 12, 2026
Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma.

|Dec 10, 2025
BRIX1 activated by mTORC1-SP1 signaling regulates ribosome biogenesis and alternative splicing to promote hepatocellular carcinoma progression.

Xuewu Tang, Weihu Ma, Yigang He

|Nov 19, 2025
Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinoma.

Fan Zhang, Zhipeng Yao, Hengjun Gao

|Jan 06, 2024
PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway.

Min Ding, Cheng Wang, Junhong Hu

|Oct 16, 2023
An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma.

Zunyong Feng, Xuanbo Zhang, Jing Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Xiaochun Jiang

1 joint publications

Xiaoyuan Chen